$0.03
0.00 (-1.64%)
Oscient Pharmaceuticals Corp (OSCI)
CAPS Rating:
A commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force, a cardiovascular product, ANTARA(r) capsules and a fluoroquinolone antibiotic, FACTIVE(r) tablets.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| les629 | 27.72 |
|
|
NS | $7.66 | -99.61% | -21.32% | -78.29 | ||
| OverAnalyze | 90.47 | 4/17/2007 |
|
5Y | $7.70 | -99.61% | -21.22% | +78.39 | ||
| pennysplants | 99.28 |
|
|
5Y | $4.82 | -99.38% | -18.02% | -81.36 | 4 Comments | |
| BasketQase | 45.14 | 12/29/2006 |
|
1Y | $5.07 | -99.41% | -18.01% | -81.40 |
RSS Headlines
Fool UK
- Active (4)
-
Ended (3)
-
All (7)
Results 1 - 4 of 4